Naris Nilubol

机构：National Institutes of Health, National Cancer Institute, National Cancer Institute, National Cancer Institute · ORCID：0000-0002-7348-7804

发表论文 306 篇 · 总被引 6466 次 · h-index 47

代表论文

• A feasibility double-blind trial of levothyroxine vs. levothyroxine-liothyronine in postsurgical hypothyroidism (2025 · Frontiers in Endocrinology · 被引 7)
• An automated pheochromocytoma and paraganglioma lesion segmentation AI-model at whole-body 68Ga- DOTATATE PET/CT (2024 · EJNMMI Research · 被引 7)
• Acute esophageal necrosis in the post-operative period: a narrative review of presentation, management, and outcomes (2024 · Journal of Thoracic Disease · 被引 6)
• Single-cell RNA-seq of small-intestinal neuroendocrine tumors reveals the cell of origin and gene expression of early tumor development (2025 · Cell Reports · 被引 4)
• A pan-cancer comparative analysis of the cancer genome atlas transcriptomic TIL-immune signatures (2025 · Cancer Immunology Immunotherapy · 被引 3)
• Expanded GEP-NET organoid culture for personalized therapy evaluation (2026 · Science Advances · 被引 1)